ALTH Allos Therapeutics, Inc. (MM)

Federman & Sherwood Announces That a Securities Class Action Lawsuit Was Filed Against Allos Therapeutics, Inc. OKLAHOMA CITY, June 2 /PRNewswire/ -- On May 19, 2004, the class action lawsuit was filed in the District Court of Colorado against Allos Therapeutics, Inc. (NASDAQ:ALTH). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material misrepresentations to the market which had the effect of artificially inflating the market price. The complaint further alleges that Allos Therapeutics, Inc. issued misleading statements to the investing public regarding the likelihood that the drug, Efaproxiral would receive approval from the FDA. However, on May 3, 2004, the Oncologic Drugs Advisory Committee for the FDA recommended that the FDA not approve Efaproxiral, which resulted in a stock price fall of ALTH of 45%. The class period is from October 23, 2000 through May 17, 2004. Plaintiff seeks to recover damages on behalf of the Class. If you are a member of the Class as described above, you may move the Court no later than sixty (60) days from May 19, 2004, to serve as a lead plaintiff for the Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995. If you wish to discuss this action, participate in this suit, or have any questions or concerns regarding this notice, or preservation of your rights, please contact: William B. Federman FEDERMAN & SHERWOOD 120 N. Robinson, Suite 2720 Oklahoma City, OK 73102 (405) 235-1560/FAX: (405) 239-2112 mailto: http://www.federmanlaw.com/ DATASOURCE: Federman & Sherwood CONTACT: William B. Federman of Federman & Sherwood, +1-405-235-1560, or fax, +1-405-239-2112, or Web site: http://www.federmanlaw.com/

Copyright